In the present study, to develop an SPECT probe for breast cancer early diagnosis, we modified AF7p with 6-hydrazinonicotinic acid (HYNIC) as the biomolecule for preparing a 99mTc-labeled MT1-MMP targeted imaging agent. This evidence concerns the gene MMP14 and breast carcinoma.